Intas Ahmedabad 483 Observation May 2023 | Learning from 483s

Intas Ahmedabad india formulation facility was inspected by USFDA in May 2023 and this resulted in 16 483 observations. The observations are mainly related to below aspects Aseptic processing Media Fill interventions APQR Investigations Data Integrity Your queries: USFDA 483 observations Intas 483 Observations Indian Pharmaceutical Company 483 observations #usfda #USFDAInspection #USFDA483 #pharmaceutical #pharmaceuticalcompanies About the Channel: The channel provides details of pharmaceutical guidelines, important updates on pharmaceuticals and other professional topics like interview preparation, personality development etc. Contact us at: [email protected]   / proftalks1680     / 13995930   Subscribe to our channel for more informative videos:    / @proftalks1680